177 related articles for article (PubMed ID: 11260400)
1. Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes.
Tsujie M; Isaka Y; Nakamura H; Kaneda Y; Imai E; Hori M
Kidney Int; 2001 Apr; 59(4):1390-6. PubMed ID: 11260400
[TBL] [Abstract][Full Text] [Related]
2. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes.
Saeki Y; Wataya-Kaneda M; Tanaka K; Kaneda Y
Gene Ther; 1998 Aug; 5(8):1031-7. PubMed ID: 10326025
[TBL] [Abstract][Full Text] [Related]
3. EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy.
Otomo T; Yamamoto S; Morishita R; Kaneda Y
J Gene Med; 2001; 3(4):345-52. PubMed ID: 11529664
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector.
Kaneda Y; Saeki Y; Nakabayashi M; Zhou WZ; Kaneda MW; Morishita R
Hum Gene Ther; 2000 Feb; 11(3):471-9. PubMed ID: 10697121
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
6. Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome.
Satoh E; Osawa M; Tomiyasu K; Hirai H; Shimazaki C; Oda Y; Nakagawa M; Kondo M; Kinoshita S; Mazda O; Imanishi J
Biochem Biophys Res Commun; 1997 Sep; 238(3):795-9. PubMed ID: 9325170
[TBL] [Abstract][Full Text] [Related]
7. Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.
Aoki M; Morishita R; Muraishi A; Moriguchi A; Sugimoto T; Maeda K; Dzau VJ; Kaneda Y; Higaki J; Ogihara T
J Mol Cell Cardiol; 1997 Mar; 29(3):949-59. PubMed ID: 9152856
[TBL] [Abstract][Full Text] [Related]
8. Improvements in gene therapy technologies.
Kaneda Y
Mol Urol; 2001; 5(2):85-9. PubMed ID: 11690554
[TBL] [Abstract][Full Text] [Related]
9. Electroporation-mediated gene transfer that targets glomeruli.
Tsujie M; Isaka Y; Nakamura H; Imai E; Hori M
J Am Soc Nephrol; 2001 May; 12(5):949-954. PubMed ID: 11316853
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer targeting interstitial fibroblasts by the artificial viral envelope-type hemagglutinating virus of Japan liposome method.
Tsujie M; Isaka Y; Ando Y; Akagi Y; Kaneda Y; Ueda N; Imai E; Hori M
Kidney Int; 2000 May; 57(5):1973-80. PubMed ID: 10792616
[TBL] [Abstract][Full Text] [Related]
11. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.
Hirai H; Satoh E; Osawa M; Inaba T; Shimazaki C; Kinoshita S; Nakagawa M; Mazda O; Imanishi J
Biochem Biophys Res Commun; 1997 Dec; 241(1):112-8. PubMed ID: 9405242
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel fusogenic viral liposome system (HVJ-liposomes) and its applications to the treatment of acquired diseases.
Kaneda Y
Mol Membr Biol; 1999; 16(1):119-22. PubMed ID: 10332746
[TBL] [Abstract][Full Text] [Related]
13. Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates.
Tsuboniwa N; Morishita R; Hirano T; Fujimoto J; Furukawa S; Kikumori M; Okuyama A; Kaneda Y
Hum Gene Ther; 2001 Mar; 12(5):469-87. PubMed ID: 11268281
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy using HVJ-liposomes: the best of both worlds?
Kaneda Y; Saeki Y; Morishita R
Mol Med Today; 1999 Jul; 5(7):298-303. PubMed ID: 10377521
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer.
Saeki Y; Matsumoto N; Nakano Y; Mori M; Awai K; Kaneda Y
Hum Gene Ther; 1997 Nov; 8(17):2133-41. PubMed ID: 9414261
[TBL] [Abstract][Full Text] [Related]
16. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes.
Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R
J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050
[TBL] [Abstract][Full Text] [Related]
17. Fusigenic liposome-mediated DNA transfer into cardiac myocytes.
Ellison KE; Bishopric NH; Webster KA; Morishita R; Gibbons GH; Kaneda Y; Sato B; Dzau VJ
J Mol Cell Cardiol; 1996 Jul; 28(7):1385-99. PubMed ID: 8841927
[TBL] [Abstract][Full Text] [Related]
18. Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo.
Tu G; Kirchmaier AL; Liggitt D; Liu Y; Liu S; Yu WH; Heath TD; Thor A; Debs RJ
J Biol Chem; 2000 Sep; 275(39):30408-16. PubMed ID: 10856307
[TBL] [Abstract][Full Text] [Related]
19. Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter.
Kim YD; Park KG; Morishita R; Kaneda Y; Kim SY; Song DK; Kim HS; Nam CW; Lee HC; Lee KU; Park JY; Kim BW; Kim JG; Lee IK
Gene Ther; 2006 Feb; 13(3):216-24. PubMed ID: 16177820
[TBL] [Abstract][Full Text] [Related]
20. Efficient gene transfer method into the whole heart through the coronary artery with hemagglutinating virus of Japan liposome.
Sawa Y; Kadoba K; Suzuki K; Bai HZ; Kaneda Y; Shirakura R; Matsuda H
J Thorac Cardiovasc Surg; 1997 Mar; 113(3):512-8; discussion 518-9. PubMed ID: 9081096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
